Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

APIDULCIS: Extended Anticoagulation With Low-dose Apixaban After a Standard Course Anticoagulation in Patients With a First Venous Thromboembolism Who Have Positive D-dimer

NCT03678506 is registered in ClinicalTrials.gov with Arianna Anticoagulazione Foundation as lead sponsor.

NCT NCT03678506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03678506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
APIDULCIS: Extended Anticoagulation With Low-dose Apixaban After a Standard Course Anticoagulation in Patients With a First Venous Thromboembolism Who Have Positive D-dimer
Lead sponsor
Arianna Anticoagulazione Foundation
Phase
Phase 4
Overall status
Terminated
Start date
August 16, 2018
Completion date
January 31, 2023
Enrollment
800 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulants, venous thromboembolism